Abstract
Impact of Molecular Response at Specific Timepoints in Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Second Generation Tyrosine Kinase Inhibitors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have